MAPT and Alzheimer disease: Our data support the possibility that impaired tau function may be crucial for insulin resistance, but it should be noted that metabolic impairments have also been reported in APP-associated mouse models of AD (e.g. APP/PSEN1 mice [38] and 3xTg-AD [39].